New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - acipimox 250mg - capsule - 250 mg - active: acipimox 250mg excipient: colloidal hydrated silica gelatin iron oxide red iron oxide yellow magnesium stearate sodium laurilsulfate starch titanium dioxide - olbetam is indicated for the treatment of lipid disorders characterised by elevated plasma levels of triglycerides (fredrickson type iv hyperlipoproteinaemia), or both triglycerides and cholesterol (type iib hyperlipoproteinaemia). olbetam should be prescribed only for patients with lipid or lipoprotein abnormalities demonstrated by laboratory tests and where diet alone is insufficient to correct the condition.

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

pfizer sa-nv - acipimox 250 mg - capsule, hard - 250 mg - acipimox 250 mg - acipimox

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

pfizer ltd - acipimox - oral capsule - 250mg

Singapore - English - HSA (Health Sciences Authority)

pfizer private limited - acipimox - capsule - 250 mg - acipimox 250 mg

Namibia - English - Namibia Medicines Regulatory Council

pfizer laboratories (pty) ltd - acipimox - capsules - acipimox capsule 250mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sigma pharmaceuticals plc - acipimox - oral capsule - 250mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

lexon (uk) ltd - acipimox - oral capsule - 250mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

mawdsley-brooks & company ltd - acipimox - oral capsule - 250mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

waymade healthcare plc - acipimox - oral capsule - 250mg

Bangladesh - English - DGDA (Directorate General of Drug Administration)

the white horse pharmaceuticals ltd. - ciprofloxacin - tablet - 500 mg